GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects (Q37396567)

20 August 2017

1 reference

title

GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects (English)

1 reference

20 August 2017

Melanie Sulistio

1

1 reference

20 August 2017

Curtis Carothers

2

1 reference

20 August 2017

Mandeep Mangat

3

1 reference

20 August 2017

Mike Lujan

4

1 reference

20 August 2017

Rene Oliveros

5

1 reference

20 August 2017

Robert Chilton

6

1 reference

20 August 2017

1 March 2009

1 reference

Current Atherosclerosis Reports

20 August 2017

1 reference

20 August 2017

11

1 reference

20 August 2017

93-99

1 reference

20 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-009-0015-9

20 August 2017

0 references

cites work

Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0015-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0015-9

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0015-9

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0015-9

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0015-9

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

12 December 2020

Switching metabolic genes to build a better heart

1 reference

12 December 2020

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

1 reference

12 December 2020

Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.

1 reference

12 December 2020

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

12 December 2020

Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart

1 reference

12 December 2020

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes

1 reference

12 December 2020

International Union of Pharmacology. XXXV. The glucagon receptor family

1 reference

12 December 2020

Myocardial substrate metabolism in the normal and failing heart

1 reference

12 December 2020

Maximum oxidative phosphorylation capacity of the mammalian heart

1 reference

12 December 2020

Realizing the clinical potential of ischemic preconditioning and postconditioning.

1 reference

12 December 2020

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

1 reference

12 December 2020

Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride

1 reference

12 December 2020

Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors

1 reference

12 December 2020

Ischemic preconditioning and preinfarction angina in the clinical arena

1 reference

12 December 2020

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

1 reference

12 December 2020

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

1 reference

12 December 2020

Apoptosis as a therapeutic target in acutely ischemic myocardium

1 reference

12 December 2020

Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium

1 reference

12 December 2020

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

1 reference

12 December 2020

Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs

1 reference

12 December 2020

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

1 reference

12 December 2020

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

1 reference

12 December 2020

Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model

1 reference

12 December 2020

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

12 December 2020

Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease

1 reference

12 December 2020

Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure

1 reference

12 December 2020

Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.

1 reference

12 December 2020

GLP-1 inhibition of pancreatic islet cell apoptosis.

1 reference

12 December 2020

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

1 reference

12 December 2020

Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol

1 reference

12 December 2020

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

1 reference

12 December 2020

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation

1 reference

12 December 2020

Postprandial lipoproteins and progression of coronary atherosclerosis

1 reference

12 December 2020

Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines

1 reference

12 December 2020

Three good reasons for heart surgeons to understand cardiac metabolism

1 reference

12 December 2020

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

12 December 2020

Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting

1 reference

12 December 2020

Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?

1 reference

12 December 2020

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

1 reference

12 December 2020

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

12 December 2020

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

1 reference

12 December 2020

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

1 reference

12 December 2020

10.1007/S11883-009-0015-9

Identifiers

DOI

1 reference

20 August 2017

1 reference